More articles from Clinical (Oncology: GU)

You have access
Feasibility of ^99mTc-MIP-1404 for SPECT/CT imaging and subsequent PSMA-radioguided surgery in early biochemical recurrent prostate cancer: a case series of 9 patients
Daniel Koehler, Markus Sauer, Susanne Klutmann, Ivayla Apostolova, Wencke Lehnert, Lars Budäus, Sophie Knipper and Tobias Maurer

Journal of Nuclear Medicine July 14, 2022, jnumed.122.263892; DOI: https://doi.org/10.2967/jnumed.122.263892
You have access
Diagnostic accuracy of ^99mTc-Sestamibi SPECT/CT for characterization of solid renal masses
Ashwin Singh Parihar, Joyce Mhlanga, Carrie Ronstrom, Lisa R Schmidt, Robert S Figenshau, Farrokh Dehdashti and Richard L Wahl

Journal of Nuclear Medicine June 30, 2022, jnumed.122.264329; DOI: https://doi.org/10.2967/jnumed.122.264329
You have access
The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on ⁶⁸Ga-PSMA-11 PET/CT in Primary Prostate Cancer Patients
Hinke Siebinga, Judith olde Heuvel, Erik-Jan Rijkhorst, Jeroen J.M.A. Hendrikx and Berlinda J. de Wit - van der Veen

Journal of Nuclear Medicine June 9, 2022, jnumed.122.264101; DOI: https://doi.org/10.2967/jnumed.122.264101
You have access
Pretherapeutic Comparative Dosimetry of ¹⁷⁷Lu-rhPSMA-7.3 and ¹⁷⁷Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber

Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671
You have access
Using, ⁶⁸Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer: an application of EAU/EANM recommendations in clinical practice.
Chloé S Denis, François Cousin, Bram De Laere, Roland Hustinx, Brieuc R Sautois and Nadia Withofs

Journal of Nuclear Medicine May 12, 2022, jnumed.121.263611; DOI: https://doi.org/10.2967/jnumed.121.263611
You have access
Correlation of ⁶⁸Ga-RM2 PET with Post-Surgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
Heying Duan, Lucia Baratto, Richard E. Fan, Simon John Christoph Soerensen, Tie Liang, Benjamin Inbeh Chung, Alan Eih Chih Thong, Harcharan Gill, Christian Kunder, Tanya Stoyanova, Mirabela Rusu, Andreas M. Loening, Pejman Ghanouni, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn and Andrei Iagaru

Journal of Nuclear Medicine May 12, 2022, jnumed.122.263971; DOI: https://doi.org/10.2967/jnumed.122.263971
You have access
⁶⁸Ga-PSMA-11 PET/MRI in patients with newly diagnosed intermediate or high-risk prostate adenocarcinoma: PET findings correlate with outcomes after definitive treatment
Farshad Moradi, Heying Duan, Hong Song, Guido A Davidzon, Benjamin I Chung, Alan E C Thong, Andreas M Loening, Pejman Ghanouni, Geoffrey Sonn and Andrei Iagaru

Journal of Nuclear Medicine May 5, 2022, jnumed.122.263897; DOI: https://doi.org/10.2967/jnumed.122.263897
You have access
A Comparison of ¹⁸F-DCFPyL, ¹⁸F-NaF, and ¹⁸F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer
Aloÿse Fourquet, Adrian Rosenberg, Esther Mena, Joanna J. Shih, Baris Turkbey, Maxime Blain, Ethan Bergvall, Frank Lin, Stephen Adler, Ilhan Lim, Ravi A. Madan, Fatima Karzai, James L. Gulley, William L. Dahut, Bradford J. Wood, Richard Chang, Elliot Levy, Peter L. Choyke and Liza Lindenberg

Journal of Nuclear Medicine May 1, 2022, 63 (5) 735-741; DOI: https://doi.org/10.2967/jnumed.121.262371
You have access
Detection of Additional Primary Neoplasms on ¹⁸F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
Ashwin Singh Parihar, Lisa R. Schmidt, Farrokh Dehdashti and Richard L. Wahl

Journal of Nuclear Medicine May 1, 2022, 63 (5) 713-719; DOI: https://doi.org/10.2967/jnumed.121.262647
You have access
Outcome of patients with PSMA-PET/CT screen failure by VISION criteria and treated with ¹⁷⁷Lu-PSMA therapy: a multicenter retrospective analysis
Masatoshi Hotta, Andrei Gafita, Johannes Czernin and Jeremie Calais

Journal of Nuclear Medicine April 14, 2022, jnumed.121.263441; DOI: https://doi.org/10.2967/jnumed.121.263441

Main menu

User menu

Search

More articles from Clinical (Oncology: GU)

Pages